WO2008126517A1 - 哺乳動物における新規slc17型トランスポータータンパク質およびその利用 - Google Patents
哺乳動物における新規slc17型トランスポータータンパク質およびその利用 Download PDFInfo
- Publication number
- WO2008126517A1 WO2008126517A1 PCT/JP2008/053878 JP2008053878W WO2008126517A1 WO 2008126517 A1 WO2008126517 A1 WO 2008126517A1 JP 2008053878 W JP2008053878 W JP 2008053878W WO 2008126517 A1 WO2008126517 A1 WO 2008126517A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- slc17
- mammal
- novel
- transporter protein
- type transporter
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
Abstract
ATP輸送を担うトランスポーターおよびそれをコードする遺伝子を単離することを本発明の課題とする。さらに、そのようなトランスポーターを用いる、中枢神経における疼痛や血小板由来のATPによる血液凝固などを処置および/または調節するための薬剤のスクリーニング法を提供することを、本発明の課題とする。本発明に従って、ATP輸送を担うトランスポーターおよびそれをコードする遺伝子が単離された。さらに、そのようなトランスポーターを用いる、中枢神経における疼痛や血小板由来のATPによる血液凝固などを処置および/または調節するための薬剤のスクリーニング法が提供される。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008526701A JP5219146B2 (ja) | 2007-03-30 | 2008-03-04 | 哺乳動物における新規slc17型トランスポータータンパク質およびその利用 |
EP08721298A EP2159281B1 (en) | 2007-03-30 | 2008-03-04 | Novel slc17-type transporter protein in mammal and use thereof |
US12/594,149 US7951595B2 (en) | 2007-03-30 | 2008-03-04 | Methods for screening modulators of SLC17-type anion transport activity |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007095055 | 2007-03-30 | ||
JP2007-095055 | 2007-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008126517A1 true WO2008126517A1 (ja) | 2008-10-23 |
Family
ID=39863675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/053878 WO2008126517A1 (ja) | 2007-03-30 | 2008-03-04 | 哺乳動物における新規slc17型トランスポータータンパク質およびその利用 |
Country Status (4)
Country | Link |
---|---|
US (1) | US7951595B2 (ja) |
EP (1) | EP2159281B1 (ja) |
JP (1) | JP5219146B2 (ja) |
WO (1) | WO2008126517A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017126700A1 (ja) * | 2016-01-20 | 2017-07-27 | 芳則 森山 | 小胞型ヌクレオチドトランスポーター活性阻害剤 |
CN116803424A (zh) * | 2023-08-24 | 2023-09-26 | 上海懿贝瑞生物医药科技有限公司 | Slc17a5基因抑制剂及其用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066744A2 (en) * | 2000-03-06 | 2001-09-13 | Lexicon Genetics Incorporated | Human transporter proteins and polynucleotides encoding the same |
WO2001075164A2 (en) * | 2000-03-30 | 2001-10-11 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420544B1 (en) * | 1999-05-19 | 2002-07-16 | Smithkline Beecham Corporation | Polynucleotide and polypeptide sequences encoding murine organic anion transporter 5 (mOATP5) |
EP1257646A2 (en) * | 2000-02-25 | 2002-11-20 | Incyte Genomics, Inc. | Transporters and ion channels |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
US6972187B2 (en) * | 2000-05-12 | 2005-12-06 | Millennium Pharmaceuticals, Inc. | OAT5 molecules and uses therefor |
US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
-
2008
- 2008-03-04 US US12/594,149 patent/US7951595B2/en not_active Expired - Fee Related
- 2008-03-04 EP EP08721298A patent/EP2159281B1/en not_active Not-in-force
- 2008-03-04 JP JP2008526701A patent/JP5219146B2/ja not_active Expired - Fee Related
- 2008-03-04 WO PCT/JP2008/053878 patent/WO2008126517A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066744A2 (en) * | 2000-03-06 | 2001-09-13 | Lexicon Genetics Incorporated | Human transporter proteins and polynucleotides encoding the same |
WO2001075164A2 (en) * | 2000-03-30 | 2001-10-11 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
Non-Patent Citations (58)
Title |
---|
"DNA Cloning 1: Core Techniques, A practical Approach", 1995, OXFORD UNIVERSITY PRESS |
"Experimental Methods in Transfection & Expression Analysis", 1997, YODOSHA |
"Matrices for Detecting Distance Relationships: Atlas of Protein Sequence and Structure", 1978, NATIONAL BIOMEDICAL RESEARCH FOUNDATION |
"Molecular Cloning", article "Current Protocols in Molecular Biology" |
"Vectors: A Survey of Molecular Cloning Vectors and Their Uses", 1988 |
ADAMS, R.L. ET AL.: "Biochemistry of the Nucleic Acids", 1992, CHAPMAN & HALL |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, no. 3, 1990, pages 403 - 410 |
ALTSCHUL ET AL., NATURE GENETICS, vol. 3, 1993, pages 266 - 272 |
ALTSCHUL ET AL., NUC. ACIDS RES., vol. 25, 1997, pages 3389 - 3402 |
ANDERSON ET AL.: "Nucleic Acid Hybridization: A practical Approach", IRL PRESS LIMITED |
ANDERSON ET AL.: "Nucleic Acid Hybridization: A Practical Approach", vol. IV, IRL PRESS LIMITED |
AUSUBEL F.A. ET AL.: "Current Protocols in Molecular Biology", 1998, WILEY |
AUSUBEL, F.M.: "Current Protocols in Molecular Biology", 1987, GREENE PUB. ASSOCIATES AND WILEY- INTERSCIENCE |
AUSUBEL, F.M.: "Molecular Biology", 1999, WILEY, AND ANNUAL UPDATES, article "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols" |
AUSUBEL, F.M.: "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology", 1989, GREENE PUB. ASSOCIATES AND WILEY-INTERSCIENCE |
AUSUBEL, F.M.: "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology", 1995, GREENE PUB. ASSOCIATES |
AUSUBEL: "Short Protocols in Molecular Biology: A Compendium of Methods from Current Protocols in Molecular Biology", 1992, GREENE PUB. ASSOCIATES |
BANKSTON LA; GUIDOTTI G., J. BIOL. CHEM., vol. 271, 1996, pages 17132 - 17138 |
BLACKBURN, G.M. ET AL.: "Nucleic Acids in Chemistry and Biology", 1996, OXFORD UNIVERSITY PRESS |
BURNSTOCK G., TIPS, vol. 27, 2006, pages 166 - 176 |
COCO S ET AL., J BIOL. CHEM., vol. 278, 2003, pages 1354 - 1362 |
ECKSTEIN, F.: "Oligonucleotides and Analogues: A Practical Approach", 1991, IRL PRESS |
ELBASHIR S.M. ET AL.: "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells", NATURE, vol. 411, 2001, pages 494 - 498, XP001167187 * |
ELBASHIR S.M. ET AL.: "RNA interference is mediated by 21- and 22-nucleotide RNAs", GENES AND DEVELOPMENT, vol. 15, 2001, pages 188 - 200, XP002204651 * |
ENOSAWA S.: "III. Nano Seikagakukei ni yoru Hisaibosei Taisha Kino Daigae Device no Kaihatsu Kenkyu Sochika e Muketa Kakushu Sozai Oyobi Kiban Gijutsu no Togo, Nanotechnology ni yoru Kinoteki. Kozoteki Seitai Daigae Device no Kaihatsu", HEISEI 15 NENDO SOKATSU.BUNTAN KENKYU HOKOKUSHO, 2004, pages 151 - 164 * |
GAIT, M.J.: "Oligonucleotide Synthesis: A Practical Approach", 1985, IRL PRESS |
GAIT, M.J.: "Oligonucleotide Synthesis: A Practical Approach", 1990, IRL PRESS |
GONNET ET AL., CIENCE, vol. 256, 1992, pages 1443 - 1445 |
HENIKOFF; HENIKOFF, PROTEINS, vol. 17, 1993, pages 49 - 61 |
HERMANSON, G.T.: "Bioconjugate Techniques", 1996, ACADEMIC PRESS |
HIGGINS ET AL., METHODS ENZYMOL., vol. 266, 1996, pages 383 - 402 |
INNIS, M.A. ET AL.: "PCR Strategies", 1995, ACADEMIC PRESS |
INNIS, M.A.: "PCR Protocols: A Guide to Methods and Applications", 1990, ACADEMIC PRESS |
JUGE N ET AL., J. BIOL. CHEM., vol. 281, 2006, pages 39499 - 39506 |
JUGE N. ET AL.: "Vesicular glutamate transporter contains two independent transport machineries", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 281, no. 51, 2006, pages 39499 - 39506, XP008120904 * |
KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2267 - 2268 |
LAZAROWSKI E: "Purinergic signaling in neuron-glia interactions", vol. 276, 2006, WILEY, pages: 73 - 90 |
MAYINGER P; BANKAITIS VA; MEYER DI., J CELL BIOL., vol. 131, 1995, pages 1377 - 1386 |
MORIYAMA Y ET AL., J. BIOL. CHEM., vol. 266, 1991, pages 22141 - 22146 |
MORIYAMA Y.: "Membrane energization by proton pumps is important for compartmentalization of drugs and toxins: a new type of active transport", THE JOURNAL OF EXPERIMENTAL BIOLOGY, vol. 199, 1996, pages 1447 - 1454, XP008120906 * |
MORIYAMA Y; YAMAMOTO A, J. BIOL. CHEM., vol. 270, 1995, pages 22314 - 22320 |
MORIYAMA, Y.; NELSON, N, J. BIOL. CHEM., vol. 263, 1988, pages 8521 - 8527 |
NELSON N; CIDON S; MORIYAMA Y., METHOD ENZYMOL, vol. 157, 1988, pages 619 - 633 |
OKAYAMA ET AL., MOL. CELL BIOL., vol. 5, pages 1136 |
PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, no. 8, 1988, pages 2444 - 2448 |
POUWELS ET AL.: "Cloning Vectors: A Laboratory Manual", 1985, ELSEVIER, N.Y. |
PUGLIELLI L; MANDON EC; HIRSCHBERG CB., J BIOL. CHEM., vol. 274, 1999, pages 12665 - 12669 |
SAKATA K. ET AL.: "Cloning of a lymphatic peptide/histidne transporter", BIOCHEMICAL JOURNAL, vol. 356, 2001, pages 53 - 60, XP008120905 * |
SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 1989, COLD SPRING HARBOR LABORATORY |
SAMBROOK J ET AL.: "Molecular Cloning: A Laboratory Manual", 1987, COLD SPRING HARBOR LABORATORY PRESS |
SAMBROOK J. ET AL.: "Molecular Cloning: A Laboratory Manual", 2001, COLD SPRING HARBOR |
See also references of EP2159281A4 |
SHABAROVA, Z. ET AL., ADVANCED ORGANIC CHEMISTRY OF NUCLEIC ACIDS, 1994 |
SNINSKY, J.J. ET AL.: "PCR Applications: Protocols for Functional Genomics", 1999, ACADEMIC PRESS |
SUGGS ET AL.: "Developmental Biology Using Purified Genes", 1981, pages: 683 |
THOMAS ET AL., CELL, vol. 51, 1987, pages 503 |
THOMPSON ET AL., NUCLEIC ACIDS RES., vol. 22, no. 2, 1994, pages 4673 - 4680 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017126700A1 (ja) * | 2016-01-20 | 2017-07-27 | 芳則 森山 | 小胞型ヌクレオチドトランスポーター活性阻害剤 |
CN116803424A (zh) * | 2023-08-24 | 2023-09-26 | 上海懿贝瑞生物医药科技有限公司 | Slc17a5基因抑制剂及其用途 |
CN116803424B (zh) * | 2023-08-24 | 2023-11-28 | 上海懿贝瑞生物医药科技有限公司 | Slc17a5基因抑制剂及其用途 |
Also Published As
Publication number | Publication date |
---|---|
US20100167411A1 (en) | 2010-07-01 |
JPWO2008126517A1 (ja) | 2010-07-22 |
EP2159281A1 (en) | 2010-03-03 |
EP2159281A4 (en) | 2010-12-15 |
EP2159281B1 (en) | 2012-09-26 |
US7951595B2 (en) | 2011-05-31 |
JP5219146B2 (ja) | 2013-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE531383T1 (de) | Therapeutische verwendung eines wachstumsfaktors, metrnl | |
WO2007143098A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
WO2007143090A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
NO20092741L (no) | DR6-antagonister og anvendelse derav ved behandling av neurologiske forstyrrelser | |
NO2014028I2 (no) | Glukopyranosyl-substituerte benzenderivater, fremgangsmåte for fremstilling av disse, fysiologisk akseptable salter av slike forbindelser, medikamenter inneholdende slike forbindelser og kombinasjoner med andre aktive substanser samt deresanvendelse for fremstilling av medikamenter for behandling av sykdom | |
WO2010017196A3 (en) | Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
WO2011097181A3 (en) | Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders | |
WO2005112981A3 (en) | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells | |
WO2006127007A3 (en) | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions | |
HK1118210A1 (en) | Compositions and methods for treating cardiac conditions | |
NO20081842L (no) | Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer | |
BRPI0810942A2 (pt) | método para tratar, previnir, retardar o início ou o desenvolvimento de uma condição, método para promover a diferenciação ou proliferação de uma célula, método para estimular o crescimento de neuritos ou para intensificar a neurogênese num indivíduo, método para auxiliar no tratamento de um indivíduo, método para diferenciar células-tronco multipotenciais, composição farmacêutica, e kit. | |
WO2008008770A3 (en) | 6, 9-disubstituted purine derivatives and their use for treating skin | |
WO2006096640A3 (en) | Use of neuronal precursor cells for treatment of central nervous system lesions | |
WO2006009765A3 (en) | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells | |
WO2005030240A3 (en) | Vege-cor vege-d materials and methods for stimulation of neural stem cells | |
WO2008157791A3 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones | |
WO2006138714A3 (en) | Naphthyridine compounds | |
WO2009023710A3 (en) | Xanthohumol-enriched hop extract | |
MX2009012969A (es) | Grelina no acilada como agente terapeutico en el tratamiento de trastornos metabolicos. | |
WO2007035092A3 (en) | Vhh for the diagnosis, prevention and treatment of diseases associated with protein aggregates | |
WO2007019312A3 (en) | Methods for characterizing and treating cognitive impairment in aging and disease | |
WO2008147483A8 (en) | Neurogenic compounds | |
SG165385A1 (en) | Novel physiological substance nesfatin, substance relevant thereto, and use of the substances | |
WO2007035722A8 (en) | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2008526701 Country of ref document: JP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08721298 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008721298 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12594149 Country of ref document: US |